C-Reactive Protein Qualitative

380
4.1
NABL, CAP, ISO
ADD TO CART
Overview
Interpretations
FAQ's
C-Reactive Protein Qualitative

Overview of C-Reactive Protein Qualitative

What is C-Reactive Protein Qualitative?

C-reactive Protein (CRP) is a protein secreted by the liver in response to inflammation caused by injury, infection, or otherwise. The C-reactive protein (Qualitative) test detects the presence of increased C-reactive protein in the blood. CRP is a non-specific marker of inflammation and can rise in any inflammatory condition.

Sample Type

The sample type collected for C-Reactive Protein Qualitative is: Blood

Preparation for C-Reactive Protein Qualitative

  • Do not eat or drink anything other than water for 8-12 hours before the test.

Why Get Tested for C-Reactive Protein Qualitative?

The C-reactive Protein Test is performed:

·         To help detect the presence of an acute bacterial infection

·         To help detect autoimmune diseases

·         To monitor treatment for infection, inflammation, autoimmune diseases, and cancer

Understand more about C-Reactive Protein Qualitative

C-reactive Protein or CRP is an acute phase reactant protein which is produced and secreted by the liver in response to any inflammation in the body, which may be caused by tissue injury, infection, or autoimmune diseases. CRP levels increase in patients with trauma, heart attack, autoimmune diseases, bacterial infections, sepsis, post surgery, cancer, etc. CRP levels are often increased before the onset of other symptoms of inflammation such as pain, fever, etc. CRP levels in blood fall as the inflammation subsides.


CRP Qualitative Test detects the presence of increased CRP in blood. Another version of the CRP test called CRP Quantitative Test measures the levels of CRP in blood and is prescribed more routinely. CRP test is performed to determine the presence of an inflammation or to monitor the treatment and progress of an inflammatory condition. It is a non-specific test. It can neither diagnose a condition by itself nor can it determine the location of a particular inflammation or disease. Other tests along with physical examination are performed to diagnose a particular condition and determine the location.


CRP test can detect flare-ups in a chronic inflammatory condition, as well as is useful in monitoring response to treatment.

A variant of the CRP test is the High Sensitivity C-reactive Protein Test (hs-CRP) which is more sensitive for CRP levels and can detect blood CRP levels at a lower concentration than the standard CRP Test. The hs-CRP Test is performed usually to determine the risk of development of cardiovascular diseases in otherwise healthy individuals.



What Results of C-Reactive Protein Qualitative mean?

Interpretations

A positive test result means that the CRP levels in the blood are increased.

Higher CRP levels indicate the presence of an inflammation which may be caused by an infection, trauma, autoimmune diseases, cancers, etc.

The CRP Test can only detect the presence of an inflammatory condition. Other tests and physical examinations are performed to diagnose a particular condition.


Patient Concerns about C-Reactive Protein Qualitative

Frequently Asked Questions about C-Reactive Protein Qualitative

Q. What is the difference between CRP and highly sensitive CRP (hsCRP)?
Both tests measure the same protein in the blood. The hsCRP is used in healthy people to determine their risk for cardiovascular disease.
Q. How is this test performed?
This test is performed on a blood sample. A syringe with a fine needle attached is used to withdraw blood sample from a blood vessel in your arm generally from the inner side of the elbow area. The doctor, nurse or the phlebotomist will tie an elastic band around your arm which will help the blood vessels to swell with blood and hence makes it easier to withdraw blood. You may be asked to tightly clench your fist. Once the veins are clearly visible, the area is cleaned with an antiseptic solution and then the needle is inserted into the blood vessel to collect the sample. You may feel a tiny pinprick during the procedure. Blood sample once collected is then sent to the laboratory.
+ more

Provided By

NABL

CAP

ISO

With a decade of experience under its belt, Oncquest is known for its excellence in Clinical Diagnostics. From its first avatar as an R&D focused entity, Oncquest has evolved into a reference laboratory in the field of Oncology, and more recently into a multi-platform Pathology Services provider with a core focus in Molecular Pathology and Surgical Pathology Services. Its logistic capabilities and geographical spread makes Oncquest an ideal associate for clinical activities in India. Oncquest’s accredited quality systems ensure customer satisfaction through any of its customer-centric service offerings. Oncquest’s recent advances in the areas of Companion Diagnostics and Pharmacogenomics have also allowed for and encouraged greater penetration of Personalized Medicine into the Indian healthcare market, making it the future epicentre of the many technological advancements in healthcare, to come. Its close association with many Hospitals across India stands testament to the faith that Oncquest has instilled in the doctors and patients which avail of its services. Oncquest is fast becoming a cornerstone for a blooming healthcare industry. With over a decade of experience in the field of molecular diagnostics and pathology services, Oncquest Laboratories has earned its reputation of clinical excellence in the Indian market. Our advanced technologies and global quality systems have ensured that we stay ahead of the curve, and this has resulted in our association with some of the most advanced clinicians, hospitals and research organizations in the country. As India gets set for a clinical revolution, ushering in a trend of new healthcare services and products, Oncquest has defined its place as a partner of choice for those who bring value to our proud subcontinent. Our national reach and sizeable knowledge base allows us to be at the forefront of scientific advances, and an ideal partner for clinical activities. We strive to be connected with the best in the industry and we welcome partnership in ideas and technologies. For example, Oncquest’s early adoption and utilization of genetic sequencing technologies has resulted in many “first to market” assays, which have subsequently been adopted in several treatment and monitoring protocols. Innovation is an essential part of our DNA. We welcome challenges, and look forward to associating with you and your organizations to develop pioneering solutions and to tackle some of the most pressing issues faced in our world.

Available at Other Labs

VIEW ALL